Literature DB >> 22832168

Quantitative evaluation of periprosthetic infection by real-time polymerase chain reaction: a comparison with conventional methods.

Yushi Miyamae1, Yutaka Inaba, Naomi Kobayashi, Hyonmin Choe, Hiroyuki Ike, Takako Momose, Shusuke Fujiwara, Tomoyuki Saito.   

Abstract

Several recent studies have demonstrated the limited accuracy of conventional culture methods for diagnosing periprosthetic infections. We have applied real-time polymerase chain reaction (PCR) assays for the rapid identification of bacteria around implants and reported its utility. However, the capability of quantification is also a useful feature of this type of assay. The aim of our study was to validate the usefulness of quantitative analyses using real-time PCR of cases with clinical periprosthetic infections in comparison with more established tests, such as C-reactive protein (CRP) levels, microbiologic cultures, and histopathology. Fifty-six joints with suspected infections were reviewed retrospectively. A universal PCR assay was used to perform the quantitative analyses. The differences in the threshold cycles between clinical samples and a negative control (∆Ct) in each case were calculated. The results of the quantitative PCR assay were compared with CRP levels, microbiologic cultures, and histopathology. There was a significant correlation found between the CRP and ∆Ct values. There were also significant differences found in the ∆Ct values according to CRP levels, with higher CRP levels showing higher ∆Ct values. Similarly, there were significant differences in the ∆Ct measurements in our culture results and among our pathologic evaluations. We confirmed that quantification by universal PCR based on the ∆Ct correlated with preoperative CRP levels and was associated with the microbiologic culture results and pathologic severity. This quantification method may be valuable for assessing infection severity.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22832168     DOI: 10.1016/j.diagmicrobio.2012.06.017

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  Interleukin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection.

Authors:  Adham Elgeidi; Abd Elrahman Elganainy; Noha Abou Elkhier; Shirien Rakha
Journal:  Int Orthop       Date:  2014-08-13       Impact factor: 3.075

2.  Polymerase Chain Reaction molecular diagnostic technology for monitoring chronic osteomyelitis.

Authors:  Brian D Mariani; Daniel S Martin; Antonia F Chen; Haruyo Yagi; Sheldon S Lin; Rocky S Tuan
Journal:  J Exp Orthop       Date:  2014-08-15

Review 3.  Periprosthetic joint infections.

Authors:  Ana Lucia L Lima; Priscila R Oliveira; Vladimir C Carvalho; Eduardo S Saconi; Henrique B Cabrita; Marcelo B Rodrigues
Journal:  Interdiscip Perspect Infect Dis       Date:  2013-08-19

Review 4.  Microbial Identification Using DNA Target Amplification and Sequencing: Clinical Utility and Impact on Patient Management.

Authors:  Tinzar Basein; Bradley J Gardiner; Gabriela M Andujar Vazquez; Andrew S Joel Chandranesan; Arthur R Rabson; Shira Doron; David R Snydman
Journal:  Open Forum Infect Dis       Date:  2018-10-10       Impact factor: 3.835

5.  Detection of mecA and 16S rRNA Genes Using Real-Time PCR Can Be Useful in Diagnosing Iliopsoas Abscess, Especially in Culture-Negative Cases: RT-PCR for Iliopsoas Abscess.

Authors:  Hyonmin Choe; Naomi Kobayashi; Yohei Ito; Hiroyuki Ike; Taro Tezuka; Masanobu Takeyama; Yusuke Kawabata; Yutaka Inaba
Journal:  Biomed Res Int       Date:  2022-02-11       Impact factor: 3.411

6.  Different diagnostic properties of C-reactive protein, real-time PCR, and histopathology of frozen and permanent sections in diagnosis of periprosthetic joint infection.

Authors:  Yushi Miyamae; Yutaka Inaba; Naomi Kobayashi; Hyonmin Choe; Yohei Yukizawa; Hiroyuki Ike; Tomoyuki Saito
Journal:  Acta Orthop       Date:  2013-11-18       Impact factor: 3.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.